9
Participants
Start Date
June 30, 2010
Primary Completion Date
November 30, 2012
Study Completion Date
April 3, 2013
propranolol
Propranolol hydrochloride is a synthetic beta-adrenergic receptor-blocking agent. This will be administered in an open-label single administration to 3 cohorts (10mg, 20mg, and 40mg) of children with sickle cell disease. Patient blood will be evaluated for red cell adhesion and patient data evaluated for safety monitoring.
University of Miami, Miami
Collaborators (1)
Duke University
OTHER
University of Miami
OTHER